The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the <i>VKORC1</i> gene: a randomized controlled trial-Reference-Cited by-同舟云学术

The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial

Published:2022-01-24 Issue:1 Volume:27 Page:95-104
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Suwanawiboon Bundarika¹^ORCID,Rotchanapanya Wannaphorn¹,Mahaprom Komkrit¹,Thongnoppakhun Wanna²,Lalerd Yupaporn³,Limwongse Chanin³,Sermsathanasawadi Nuttawut⁴,Owattanapanich Weerapat¹^ORCID

Affiliation:

1. Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

2. Division of Molecular Genetics, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

3. Division of Medical Genetics, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

4. Division of Vascular Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Funder

Faculty of Medicine Siriraj Hospital, Mahidol University

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.2019891

Reference24 articles.

1. Pharmacology and Management of the Vitamin K Antagonists